Dmochowski, R, Aliotta, P, Blok, B, Castro-Diaz, D, Denys, P, Ethans, K, Joshi, M, Magyar, A, Kennelly, M. (2017) Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity. BJU (Jan).
Herschorn, S., Kohan, A., Aliotta, P., McCammon, K., Rajagopalan, S., Everaert, K. (2017) The Efficacy and Safety of Onabotulinumtoxin A or Solifenacin Compared with Placebo in Solifenacin-Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind, Phase 3b Trial. Journal of Urology (Jan).
"Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." International Neurotoxin Association Meeting (TOXINS) (2017)
"The Efficacy and Safety of Onabotulinumtoxin A and Solifenacin Compared to Placebo in Solifenacin-Naïve Patients with Idiopathic Overactive Bladder: Results from a Multicentre, Randomised, Double-Blind Trial" British Association of Urological (2016)
"Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." Society of Urodynamics, Female Pelvic Medicine & Urogentical Reconstruction (2016)
"Long Term Sustained Safety and Efficacy if Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." Italian Society of Urodynamics, (2015)
"Perirectal Hydrogel Spacer Application in Men Receiving Prostate Radiotherapy: A Prospective Multicenter Randomized Controlled Trial." American Urological Association (2015)
"Positive Response to First Onabotulinumtoxin A Treatment Persists Long-term with Repeat Treatments in Patients with Neurogenic Detrusor Overactivity" Congress of the European association of Urology (2015)
". Long Term, Sustained Safety and Efficacy of Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." American Committee for Treatment and Research in MS/European Committee for Treatment and Research (2014)
Service Activities:
Chief of Urology (2018–present)
Sisters Hospital Representative of the Catholic Health Medical Executive Committee (2016–present)
Department of Urology; Chair (2009–present)
Catholic Health System of WNY; Board Member (2007–present)
Niagara Health Care Quality Council (2005–present)
Office Professional Medical Conduct, Department of Health New York State Urologic Reviewer; Reporter (2002–present)